Trial
NCT03468140
Pilot Trial of Eculizumab Therapy to Reduce Preservation Injury in Human Macrosteatotic Liver Transplantation
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
Ochsner Health System; Alexion Pharmaceuticals, Inc.
Condition
End Stage Liver Disease
Intervention
Eculizumab
Why stopped
Unable to recruit due to COVID 19
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-08